Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:01 PM UTC
| NCT Number | NCT07546500 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer |
| Phase | PHASE3 |
| Target Enrollment | 420 participants |
| Active Locations | 12 sites in the US |
| Sponsor | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc |
| Last Updated on CT.gov | August 12, 2026 (Aug 12, 2026) |
As of October 12, 2026: Clinical trial NCT07546500 is currently recruiting participants. This phase3 study for ovarian cancer is actively seeking new participants at 12 locations across the United States. The study is sponsored by K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07546500 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07546500 was last updated Aug 12, 2026 (August 12, 2026). HelloStudys verifies this status automatically.